Can Ozempic Really Cause Vision Loss? What the Science Says

Ozempic (semaglutide) has become one of the most talked-about medications of the decade, helping millions of people manage diabetes and lose weight. But with its popularity has come a wave of new concerns—one of the most unsettling being whether it can cause vision loss. Reports of blurred vision, worsening diabetic retinopathy, and even rare cases of sudden blindness have left patients wondering: Is my eyesight at risk?

Let’s unpack what the research actually says.

The Headlines vs. The Evidence

When stories about vision loss linked to Ozempic first made headlines, the reaction was immediate: concern, confusion, and in some cases, fear. But according to Medical News Today, the evidence isn’t so clear-cut. Some studies suggest a possible link between semaglutide and eye issues, while others show no increased risk at all. Right now, experts agree on one thing: the data is still too limited to make any definitive claims.

What JAMA Ophthalmology Found

One of the most widely discussed studies comes from JAMA Ophthalmology. Researchers looked at people using semaglutide and found no significant increase in common eye problems or diabetic retinopathy.

There was a small signal that semaglutide might be associated with non-arteritic anterior ischemic optic neuropathy (NAION)—a rare condition that can cause sudden vision loss. But the study emphasized that the evidence wasn’t strong enough to prove that semaglutide itself was the cause. In other words: reassuring overall, but with a note of caution.

Real-World Data: A Different Picture

Clinical trials aren’t the only source of evidence. A study in BMC Medicine dug into the FDA’s adverse event reporting system and found something striking: patients on semaglutide reported vision problems far more often than patients on other diabetes or weight-loss drugs.

• Nearly 2x more reports compared to other GLP-1 drugs
  
• About 4x more reports compared to SGLT2 inhibitors
  
• Significantly higher than metformin, DPP-4 inhibitors, and others

Does that mean semaglutide is definitely causing vision issues? Not necessarily. These reports show associations, not causation. People who experience side effects are more likely to report them, and many patients taking semaglutide already have health conditions—like diabetes—that independently raise the risk for eye problems.

What Ophthalmologists Are Saying

The American Academy of Ophthalmology (AAO) has also weighed in. They note that semaglutide may sometimes worsen diabetic retinopathy, particularly if blood sugar drops very quickly after starting the drug. Cases of blurred vision and macular complications have been reported as well.

Still, the AAO emphasizes that these risks appear to be rare. For most patients, the benefits of better glucose control and weight loss outweigh the potential downsides.

What Patients Should Do

So, should you be worried? Not necessarily—but you should be informed. Here are a few takeaways:

• Stay proactive with eye care. If you have diabetes or existing eye conditions, regular eye exams are critical—especially if you’re starting semaglutide.
  
• Report new symptoms quickly. Blurred vision, flashes, or sudden vision changes should always be taken seriously.
  
• Balance the risks and benefits. For most people, semaglutide’s benefits in controlling blood sugar and reducing cardiovascular risk far outweigh the rare reports of eye problems.

The Bottom Line

Right now, there’s no solid evidence that semaglutide directly causes vision loss. But early signals, like rare cases of NAION, worsening retinopathy, and higher-than-expected reports of eye issues—suggest this is an area that deserves more research.

For now, the message is one of cautious optimism. Ozempic remains a breakthrough treatment with huge health benefits, but both doctors and patients should keep eye health on their radar. Science is still catching up, and in the meantime, a little vigilance goes a long way.